【摘 要】
：
Background: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades.However,the clinical characteristics and prognosis of MPM patients involving lung cancer were n
【机 构】
：
Armed Police Hospital of Guangdong Province China
论文部分内容阅读
Background: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades.However,the clinical characteristics and prognosis of MPM patients involving lung cancer were not fully elucidated.
其他文献
As growing promise in engineered immune cells for cancer therapy,for example,Chimeric Antigen Receptors T cells (CAR-T) can recognize and eliminate tumor cells expressing specific antigens,optimal man
Gastric cancer is the third leading cause of cancer related death worldwide,and some of the highest mortality rates are in East Asia.Targeted cancer therapies provide new hope to patients with gastric
Melanoma is one of the most aggressive malignant diseases in human,and the best treatment outcome could be achieved when the diseases is diagnosed at the earlier stages.
In recent years,major advances have been made in interventional.Notable techniques have been developed and actually cryosurgery has positioned in an important place in solution of lung and trachea-bro
Non-small cell lung cancer (NSCLC) is the predominant type of lung cancer,the most common malignancy in the world.Although lung carcinogenesis is an extensively studied disorder,it still requires clar
Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor (EGFR) have shown promising clinical efficacy in non-squamous non-small cell lung cancer (NSCLC);however,resistance is
Lung Cancer is the most frequent cancer worldwide with more than 1,3 M new case each year.The years 2000 saw two major changes in lung cancer,the predominance of adenocarcinoma and a personalized trea
The aim of this study was to evaluate the clinical activity of another angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib,gefitinib and icotin
Lung cancer in never smokers patients is on the seventh rank,the most common cause of cancer-related mortality,then it is followed by cancers of the cervix,pancreas,and prostate.
The overexpression of epidermal growth factor receptor (EGFR) is closely associated with a poor outcome in non-small cell lung cancer (NSCLC),and EGFR is an ideal biomarker for the targeted therapy of